| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 68.9 | 64.9 | 45.8 |
| Other income | 0.4 | 1.3 | 1.4 |
| Total income | 69.3 | 66.2 | 47.2 |
| Profit before exceptional items & tax | 10.5 | 10.5 | 7.3 |
| Exceptional items | 0.0 | -0.6 | 0.0 |
| Profit before tax | 10.5 | 9.9 | 7.3 |
| Net profit | 7.8 | 6.5 | 5.5 |
| Operating margin | 15.2% | 15.0% | 15.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +41.80% |
|---|---|
| Net profit, quarter on quarter | +20.00% |
| Revenue, year on year | +50.40% |
| Operating profit, year on year | +71.20% |
| Operating profit, quarter on quarter | +9.80% |
NSE results filing, NSE: NEOCHEM. Figures extracted from the filing.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹104.70
- Market cap
- ₹179.2 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 14.9×Sector 34.5×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions Other Announcement
Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Neochem Bio Solutions Promoter Buying: ₹0.14 Cr
Promoter Swapnil R. Makati acquired 1,200 equity shares of Neochem Bio Solutions Limited for ₹0.14 Crore via an on-market purchase.
- Value
- ₹0.14 Cr
- Promoter stake change
- +0.01%
Neochem Bio Solutions Promoter Buying: ₹0.07 Cr
Promoter and MD Swapnil Makati purchased 7,200 Neochem Bio Solutions shares on NSE for ₹0.07 Crore. His stake rose from 54.70% to 54.74%.
- Value
- ₹0.07 Cr
- Promoter stake change
- +0.04%
Neochem Bio Solutions Management Change
Neochem Bio Solutions Limited has appointed Mr. Siddharth Raj as Business Head (Textiles) Corporate Accounts. This Senior Management Personnel appointment is effective August 29, 2026.